Inactief instrument

Andere talen Hi-Tech Pharmacal Co.

Aandelen

US42840B1017

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Hi Tech Pharmacal : Akorn Completes Acquisition of Hi-Tech Pharmacal	17-04-14
Hi Tech Pharmacal : Akorn Receives FTC Clearance for Hi-Tech Pharmacal Acquisition	15-04-14
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Reports Sales of $59.9 Million for the Third Quarter Ended January 31, 2014	11-03-14
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Receives Final Approval for Bromfenac Ophthalmic Solution, 0.09% (Once-A-Day)	23-01-14
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Announces Settlement Regarding Texas Pricing Investigation	26-12-13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Reports Sales of $58.6 million for the Second Quarter Ended October 31, 2013	10-12-13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on September 9, 2013	05-09-13
Hi-Tech Pharmacal Co. : HI-TECH PHARMACAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Hi-Tech Pharmacal Co., Inc. Following Announcement of Proposed Sale of Company to Akorn, Inc.	29-08-13
Hi-Tech Pharmacal Co. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Hi-Tech Pharmacal Co., Inc. Shareholders	28-08-13
Hi-Tech Pharmacal Co. : Ryan & Maniskas, LLP Announces Investigation of Hi-Tech Pharmacal Co., Inc.	28-08-13
Hi-Tech Pharmacal Co. : Akorn to Acquire Hi-Tech Pharmacal for $640 Million	27-08-13
Hi-Tech Pharmacal Co. : Health Care Products Division of Hi-Tech Pharmacal Receives FDA Warning Letter Related to Labeling Statements on Certain OTC Products	24-07-13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Release Fourth Quarter Earnings and Hold Conference Call on July 9, 2013	03-07-13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the Bank of America Merrill Lynch 2013 Health Care Conference	09-05-13
Hi-Tech Pharmacal Co. : ECR Pharmaceuticals Announces Re-launch of Zolpimist® and DexPak®, Divestiture of Hylase® and Orbivan® Brands, and Dr. Cameron Durrant Named President and CEO	30-04-13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the Needham 12th Annual Healthcare Conference	29-04-13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal Reports Sales of $64.3 Million and EPS of $0.43 for the Third Quarter Ended January 31, 2013	07-03-13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Release Third Quarter Earnings and Hold Conference Call on March 7, 2013	04-03-13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the 2013 RBC Capital Markets' Healthcare Conference	27-02-13
Hi-Tech Pharmacal Co. : Hi-Tech Pharmacal to Present at the Oppenheimer 23rd Annual Healthcare Conference	11-12-12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Hi-Tech Pharmacal Co.

Aandelen

US42840B1017

Andere talen

Filters